Neuberger Berman Group
ICPT

Neuberger Berman Group’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Neuberger Berman Group’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-5,000
Closed -$620K – 1650
2019
Q4 		$620K Buy
+5,000
New +$448K ﹤0.01% 1248
2019
Q3 		– Sell
-6,100
Closed -$485K – 1617
2019
Q2 		$485K Buy
6,100
+2,600
+74% +$233K ﹤0.01% 1300
2019
Q1 		$392K Buy
+3,500
New +$382K ﹤0.01% 1310
2014
Q2 		– Sell
-21,650
Closed -$7.14M – 1763
2014
Q1 		$7.14M Buy
+21,650
New +$7.31M 0.01% 872

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Neuberger Berman Group's ICPT Position: Q1 2020 in Review

Neuberger Berman Group sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q1 2020, closing a stake of 5,000 shares — an estimated $620K sold.

Neuberger Berman Group first reported a position in ICPT in Q1 2014 and held it in 4 quarters. The position peaked at $7.14M in Q1 2014. 188 funds tracked by Wall St. Rank hold ICPT as of Q1 2020.

  • Neuberger Berman Group reported no remaining Intercept Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
  • Neuberger Berman Group sold 5,000 Intercept Pharmaceuticals, Inc. shares in Q1 2020, an estimated $620K.
  • Neuberger Berman Group first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2014 and held it in 4 quarters.
  • Neuberger Berman Group's Intercept Pharmaceuticals, Inc. position peaked at $7.14M in Q1 2014.
  • 188 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2020.

Based on Neuberger Berman Group's 13F filing for Q1 2020, filed 14 May 2020.